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Abstract
Background: The current state of diabetes self-management (DSM) education and support for diabetic patients
is inadequate, especially for minority women who experience disproportionately high rates of diabetes mellitus (DM)
in the US. While DSM education and support enables individuals with diabetes to make positive lifestyle choices and
achieve clinical goals, this type of support is difficult to deliver in medical practice settings. Virtual reality can assist
DM patients and their clinical teams by providing effective educational tools in an engaging, learner-centered
environment that fosters self-efficacy and skill proficiency.
Methods: Our prior research demonstrated that virtual worlds are suitable for supporting DSM education.
Building upon this success, we are now investigating whether DSM virtual world medical group visits lead to similarly
effective health and educational outcomes compared to face-to-face medical group visits. Currently in year one of a
five year randomized controlled trial, we aim to compare the effectiveness of a virtual world DSM medical group visit
format versus a face-to-face DSM medical group visit format to increase physical activity and improve glucose
control (HbA1c) among Black/African American and Hispanic women with uncontrolled DM. We will also conduct a
qualitative study of participant engagement with the virtual world platform to characterize learners’ interactions with
the technology and assess its correlation with DSM behaviors and diabetes control.
Discussion: Novel methods to promote diabetes self-management are critically needed, and the use of virtual
world technology to conduct medical group visits offers a unique approach to such issue. If successful, our
intervention will increase access to culturally-sensitive diabetes care and improve patient engagement in online DSM
learning, leading to higher uptake of DSM behaviors and better diabetes control. Importantly, the program can be
easily expanded to other chronic disease areas and scaled for widespread use.
Keywords: Type 2 Diabetes; Virtual world; Medical group visits;
Diabetes self-management; RCT
Abbreviations
DM: Diabetes Mellitus; T2DM: Type 2 Diabetes Mellitus; DSM:
Diabetes Self-Management
Introduction
There are epidemic proportions of Type 2 diabetes mellitus (DM) in
the US, with over 46.3% of individuals having T2DM or pre-diabetes as
of 2014 [1]. Hispanic and non-Hispanic black women have the highest
risk of developing DM in their lifetime as compared to non-Hispanic
white women, and Hispanic, black and white males [2]. Hispanic and
Black women also report low rates of physical activity, low
consumption of fruits and vegetables, and low levels of diabetes self-
efficacy, all significant risk factors for poor glycemic control and
serious health complications.
Individuals who develop diabetes require diabetes self-management
education and support to enable them to make good choices and
achieve clinical goals; DSM education and group medical visits are
more effective in improving diabetes outcomes than usual care, as they
link lifestyle management with clinical care in peer-supported settings.
This type of support and education, however, is difficult to deliver in
medical practice settings [3]. With a shortage of healthcare providers
and a growing prevalence of diabetes, there is great need for innovative
approaches to DSM education and collaborative medical care to
address disparities in DM outcomes.
Evidence suggests that computer based e-Health inventions that are
personally relevant, contextually-situated, and culturally-tailored to the
individual, are more likely to improve disparities in health outcomes
and promote health behavior change, yet few studies focus on
promoting DSM using the virtual world [4]. Virtual worlds are 3-D,
computer based simulated environments, in which individuals create
online manifestations of self through avatars and engage in
experiences with other avatars on the platform. The use of virtual
world technology for experiential learning is a new frontier for health
behavior research and represents a novel opportunity for DSM
education.
Preliminary evidence shows that virtual worlds influence “real
world” behavior, as they are intrinsically designed for users to enact
behavioral change, test new behaviors anonymously among peers, and
restructure old habits [5-8]. As avatars, users explore environments,
meet and socialize with others, and participate in group and individual
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activities. For some, the avatar becomes a purposeful projection or
idealization of their own identify or an experiment with new identifies
[9].
The virtual world offers a novel opportunity to improve health
education by: (1) improving remote access to unique educational
programs; (2) offering immersive personal learning environments; and
(3) providing simulation-visualization exercises to enhance health
behavior change. Virtual reality can assist DM patients and their
clinical teams by providing effective educational tools in an engaging,
learner-centered environment, fostering self-efficacy and skill
proficiency.
Our recent pilot study, Women in Control 1.0, tested a virtual world
DSM group education intervention with excellent results. The study
was comprised of 89 African American women with uncontrolled DM,
most of who were ≥ 40 years old (90%), from low-income households
(82%) and had a high school education/equivalent (55%). Pilot data
shows DSM group visits conducted in Second Life, a 3-D virtual lab,
were not only feasible but as effective as face-to-face methods for
improving DM disease control and diabetes self-efficacy, and showed
significantly greater improvements in physical activity for virtual world
participants [10].
Our current research, Women in Control 2.0, builds upon the
virtual world DSM pilot program to include a medical consult
consistent with the group medical visit model and a social ecological
framework. While evidence shows the potential efficacy of Internet-
based DSM education programs, to date, little work has focused on the
use of virtual world technology for a group medical visit. To our
knowledge, the Women in Control 2.0 intervention is the only virtual
world program to include clinicians in a DSM group medical visit
format.
Methods/Design
Objectives and hypotheses
Women in Control 2.0 is a randomized controlled trial aimed to test
the comparative effectiveness of diabetes self-management medical
group visits conducted in the virtual world versus a face-to-face format
for Black/African-American and Hispanic/Latina women with
uncontrolled diabetes. Our ongoing randomized controlled trial will
assess the comparative effectiveness of the group visits in increasing
physical activity and improving diabetes control (HbA1c) at six-month
follow up. Based off our pilot data [10], we hypothesize the DSM
medical group visits delivered in the virtual world will be non-inferior
in increasing participant physical activity and improving HbA1c to
visits conducted via face-to-face format. We will also conduct a
qualitative, ethnographic study of participant engagement with the
virtual world platform and assess its correlation with real-world DSM
behaviors.
Setting and participants
All study activities will be conducted in person, at Boston Medical
Center, a large, academic teaching hospital, and online in the virtual
world platform. Patients will be eligible if they are female, 18 years or
older, self-identify as Black/African American or Hispanic/Latina, have
been diagnosed with Type II Diabetes Mellitus (T2DM), had a HbA1c
value above 8.0 at last reading, and are currently treated with diet, oral
hypoglycemic agents and/or insulin. They must also have telephone
access, can communicate in English or Spanish, can understand and
provide informed consent and are functionally capable of meeting the
activity goals in the goals. Participants will need their primary care
provider’s approval before enrolling in the study. Participants will be
excluded from the study if they have a history of diabetic ketoacidosis,
are currently or planning pregnancy, are unable or unwilling to provide
informed consent, have plans to leave the area the 6-months period of
their involvement in the study, require intermittent glucocorticoid
therapy within the last three months, have experienced an acute
coronary event with the previous six months, have a medical condition
that precludes adherence to study dietary recommendations or have a
medical or serious psychiatric illness. Those with a diagnosis of
depression or who take antidepressants are eligible.
Study design
A woman in Control 2.0 is a two-arm randomized control trial
conducted at Boston Medical Center and in a virtual world platform.
All study subjects will participate in 8-weeks of DSM medical group
visits, either in the virtual world or face-to-face format. Participants
will be stratified by preference of language (English or Spanish), and
medical group visits will be conducted in one language or the other
based on the cohort. After stratification by language, participants will
be randomized into the experimental (virtual world users) and control
conditions (face-to-face format) (Figure 1). Based off our hypotheses,
we anticipate the virtual world format will be non-inferior, and
perhaps superior, to the face to face format in improving glucose
control and increasing physical activity among the medical group visit
participants.
Recruitment
We will recruit subjects from the Diabetes and Family Medicine
clinics at BMC, and from the affiliated Boston HealthNet community
health center network. PCPs will identify patients of theirs whom they
believe would benefit from participating in the study. The PCP will
send letters containing study information to the patient, and if
interested, the patient will contact our research team by phone for
initial screening. If the patient meets the inclusion criteria for the study
based off the screening phone call and chart review by research staff,
the patient will be scheduled for an in-person enrolment appointment.
At this time, research staff will discuss with the patient the study
design, requirements, scheduling of group visits and compensation,
and the participant will give written informed consent. Baseline data
measures will then be collected, and participants will receive a laptop,
computer training and training on the virtual world platform.
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Figure 1: Schematic overview of trial design, broken down by language preference (English vs. Spanish) and randomization into intervention
condition (Virtual world) and control condition (face to face). Each cohort for the medical group visits will consist of 8-10 women each.
Intervention
At baseline, all study participants will be required to answer 9
validated questionnaires on various aspects of diabetes self-
management and patient activation and engagement (Table 1).
Participants will also have a baseline blood draw taken, to assess their
HbA1c and cholesterol. For 1 week following baseline data collection,
study subjects will wear an accelerometer, to track their physical
activity and inactivity.
Post-enrolment and baseline data collection, medical group visits
will commence weekly, either in the virtual world or face to face, based
on the randomization assignment. Groups will consist of 8-10 women,
and all study subjects will gather each week (~100 mins per week) with
their group either online or in-person throughout the 8-week
intervention. Led by a clinician and a peer-leader, participants will
progress through an interactive and collaborative DSM curriculum
with emphasis on promoting healthy food choices, physical exercise,
stress reduction and mindfulness, while better understanding how
diabetes and diabetes medications affect the body.
The Women in Control 2.0 DSM curriculum is based off the
Women in Control 1.0 program, the CDC’s Power to Prevent
curriculum [11] and the Integrative Medicine Group Visit curriculum
[12], pioneered and developed at Boston Medical Center in the
Department of Family Medicine. At each group session, participants
will have an individual, private consultation with a clinician, lasting
approximately 15 minutes. The virtual world participants will be able
to log into the virtual platform at any time in between group visits, to
interact with and explore the virtual world space.
After completion of the 8-weeks of medical group visits, the same
outcome measures collected at baseline will be collected from
participants at 8-weeks (post intervention) and at a 6-month follow up.
Focus groups and key informant interviews from select individuals will
be conducted post-intervention, to elicit their experiences with the
DSM curriculum, virtual world platform (for virtual world users) and
group medical visit.
Outcomes
The primary outcomes of this study are changes in participants’
physical activity levels and measures of HbA1c. Physical activity will be
measured in METs/hr; participants will wear an accelerometer for a
one week period, at baseline, 8-weeks and 6-months. The data will be
analyzed to determine the average change in total physical activity
from baseline to 6 months of all participants by study arm (VW vs.
face-to-face).
We will assess the average change in HbA1c (%) from baseline to 6
months of all participants by study arm from blood samples collected
and analyzed at the BMC laboratory.
Secondary outcomes include patient activation, medication
adherence, depression, clinical parameters (blood pressure, cholesterol,
and weight/BMI), dietary patterns, stress levels, functional status,
health literacy, social support, social network changes, quality of life
and health service utilization [13-22].
We will also assess participant satisfaction with the curriculum,
their confidence using computers, and self-reported adherence to DSM
behaviors [23].
All study sessions will be audio and video recorded for both face-to-
face and Second Life sessions. The primary, secondary and exploratory
outcomes of this study are detailed in Table 1, along with their
associated measurement tools and frequency of measurement.
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Specific
Aim Outcome Instrument Timeline
(1) RCT of DSM Training Using Virtual World vs. Face to Face Format to
Increase Physical Activity Levels
Primary
Outcom
e
Change in Physical
Activity Level (METs/hr)
Change in accelerometer
readings
Baseline,
Post-
interventio
n & 6
months
follow up
(2) RCT of DSM Training Using Virtual World vs. Face to Face Format to
Reduce HbA1c Levels
Primary
Outcome
Change in disease
control
Change in HbA1c from BMC
laboratory blood testing
results
 
 Change in patientactivation Change in PAM 13 score  
 Medication Adherence
Prescription fulfilment ratio
per 12b2 database claims
data analysis
 
 Depression Patient Health Questionnaire(PHQ-8)  
Seconda
ry
Outcome
s
Improvement in
cholesterol,
hypertension and body
weight
Serum LDL/HDL, BP, BMI
from BMC laboratory results,
BP readings from home
blood pressure kits, weight/
height measurements
Baseline,
Post-
interventio
n & 6
months
follow up
 Health Related Qualityof Life Q-LES-Q Screening Survey  
 Dietary Habits Multiple measures of 24-hrdietary recall  
 Functional Status Sheehan Disability Scale  
 Stress Perceived Stress Scale(PSS-10) Survey  
 Social Support MOS Social Support Survey  
 Health serviceutilization
Self-report & chart review of
hospitalizations, PCP &
specialist visits
 
(3) Qualitative Ethnographic Study of Participant Behaviors in Virtual
Environment
(Virtual World [Second Life] Participants ONLY)
 
Measure of Positive
Technological
Development to assess
influence of technology
on learning and skill
development
Positive Technological
Development Questionnaire
(PTDQ)
Baseline,
Post-
interventio
n & 6
months
follow up
Primary
Outcomes
Characterize
participants’ virtual
world resource use,
user patterns and peer
interactions in Second
Life
Ethnographic study of both
learning environments from
researcher’s field notes and
session audio recordings
 
 
Characterize Patients’
perceived DSM
educational experience
Key informant interviews with
participants in virtual world
Performed
during 8-
week
and responses to PTDQ
questionnaire
session
blocks
 
Characterize patient-
clinician interactions in
Second Life group
visits
Ethnographic study of
Second Life clinician
consultations and key
informant interviews
 
Explorator
y
Outcomes
Changes in Social
Network Metrics
Social Network Diagnostic
Tool
Baseline,
Post-
interventio
n & 6
months
follow up
 Use of social media
Self-report tracking of logins
for contracts with group
peers via survey
Performed
during 8-
week
session
blocks
Table 1: Women in Control 2.0 Study Outcomes and Measures by
Specific Aim.
Sample size calculation
This study will consider the discrete difference in the average change
in physical activity and HbA1c by study arm to be co-primary
outcomes, as measured by calculating the different in physical activity
levels and HbA1c levels from baseline to 6 month follow up for each
participant, then determining the average change across all
participants per study arm, and then between each arm. Due to the
paucity of available data determining accelerometry cut-off points for
populations with chronic disease [24], data obtained with the Women
In Control 1.0 pilot study was used to estimate the sample size
necessary to establish non-inferiority of SL to face-to-face in reducing
HbA1c (%) and increasing total physical activity levels (MET/hr). If
the improvements in the outcomes in the Second Life group exceed
those in the face-to-face group, we will assess the superiority of the
intervention condition over the control. The results of the pilot indicate
that the SL group and face-to-face group had roughly similar discrete
reductions in HbA1c on average from baseline to 6 months (-0.46 and
-0.31, respectively, with a common standard deviation of 2). Assuming
a non-inferiority margin of 0.7, a pooled standard deviation of 2, alpha
of 0.05, and targeting a power of 80%, we require 102 participants per
study arm to show non-inferiority of SL to face-to-face to account for a
clinically meaningful decrease in HbA1c. Total physical activity,
measured in MET/hr, increased significantly more from baseline to 6
months for the SL group when compared to the face-to-face group
(6.70 vs. -9.20, respectively), with a pooled standard deviation of 35.We
will assume a non-inferiority margin of 12, and under the assumption
of a pooled standard deviation of 35, alpha of 0.05, and target power of
80%, we will require 106 participants per group, for a total of 212.
Considering that the dropout rate for the pilot was low (5%), we expect
the dropout rate for this study not to exceed 7%. With this
consideration, we will enrol and randomize 228 participants, and
expect to retain 212.
Randomization
After stratification by language (English vs. Spanish), we will use
one-to-one block randomization (alternating blocks of 6 and 8) into
the intervention and control condition. Investigators are blinded to the
randomization process, but the assignment will be revealed to the
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participant and the investigators thereafter in order to conduct the
medical group visits.
Data collection and management
Research data will be stored using Research Electronic Data Capture
(REDCap), which is accessible online via a secure web portal.
Participants will be assigned a study ID which will be used on all forms
and records collected. Master lists linking participant information to
their ID number will be password protected and only accessible by the
PI and other investigators. Necessary hard copy records will be kept
locked.
Statistical analysis
Quantitative analysis will be conducted using SAS 9.3 and Microsoft
Excel 2013. Significance will be determined at a 0.05-signifncance level
for all tests. Analysis results will be compared for both primary
outcomes utilizing non-inferiority margins of 0.7% for HbA1c and 12
METs/hr for total physical activity. All qualitative analysis of focus
group and key informant interviews will utilize NVivo11 qualitative
research software, and analysis will be conducted using grounded
theory and constant comparative analysis.
Ethical considerations
The Boston University Medical Center Institutional Review Board
has approved this study protocol. All recruitment and study
procedures will strictly adhere to HIPPA regulations. The Data and
Safety Monitoring Board for this project will meet twice a year over the
study period to review safety information including any adverse events
possibly related to the interventions. All participants will give written
informed consent, in their native language (English or Spanish), and
all study activities for the individual will be conducted in that preferred
language.
Discussion
Women in Control 2.0 is a randomized controlled trial aimed to test
the comparative effectiveness of diabetes self-management medical
group visits conducted in the virtual world versus a face-to-face format
for groups of Black/African-American and Hispanic/Latina women
with uncontrolled diabetes. This research is necessary given the current
inadequacy of diabetes self-management education and support for
diabetic patients, especially for minority populations. Novel methods
to promote diabetes self-management are critically needed, and the use
of virtual world technology to conduct medical group visits offers a
unique approach to such issue.
Although research in the use of virtual worlds for patient education
and engagement is limited [25,26], we anticipate virtual world learning
may offer participants several benefits over the face-to-face format.
One of the most widely acknowledged benefits of the virtual world is
the ease of distance learning. The virtual world allows participants to
engage in learning from convenient locations, eliminating potential
challenges due to transportation and mobility due to illness burden,
and interact with a wide range of individuals who are not confined by
geographic proximity.
Beyond distance learning, the virtual world offers novel approaches
to behavioral change and experimentation with self-identity. In the
virtual world, the participant customizes the appearance of the avatar
as desired, which may or may not reflect their actual real-life
appearance. This gives them the freedom to present themselves in
more malleable fashion than in the physical world. Through actively
controlling the avatars appearance, actions and speech, the
participants is forced to be deliberate and intentional with their
actions, which may lead to a heightened awareness of the connection
between their intentions, actions and consequences through embodied
learning [27]. Instead of learning in the abstract, as in a traditional
classroom or support group, the avatar learns through experience in
the virtual world while collaborating with other avatars, which then
may translate to real life actions and behavioral change [28,29]. As
learners experiment with their avatars, they are free to test out new
behaviors, and even fail while doing so, without the real-life
consequences normally attached to such actions [9,30]. In this fashion,
participants can experience the negative and positive consequences of
lifestyle modifications and behaviors, before making these changes in
real life. This safe environment to learn, experiment, explore and
collaborate with others is crucial when trying to enact behavioral
change, and this type of applied learning in a personalized context has
been associated with successful behavioral change and improved self-
efficacy [31]. For these reasons, we anticipate the unique affordances of
the virtual world will aid our virtual world participants greatly in their
DSM efforts.
Ultimately, we aim to offer a tailored, individualized simulation-
based learning experience that links DSM education with patients’
clinical care, daily lifestyle, peer support, home and virtual world
community. If successful, this program will increase access to
culturally-sensitive diabetes care and improve patient engagement in
online DSM learning, leading to higher uptake of DSM behaviors and
better diabetes control. Importantly, the program can be easily
expanded to other chronic disease areas and scaled for widespread use.
Trial Status
This study was funded as of August 2015. This randomized control
trial is in pre-implementation development. RCT recruitment and
enrolment will commence in January 2017. Participants will be
followed for 6 months.
Trial Registration
Clinical Trial Registry Number: NCT-02726425.
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